Market Rank #45 · Evidence Tier A

Ukraine
Neuroscience Intelligence

Ukraine neuroscience intelligence: 60 indexed trials, 1 institutions, research score 24.69.

⚗
60Indexed trials
↗
10Recruiting
⌂
1Research institutions
◎
24.7Research score

Evidence profile

32Sponsors
12Disease areas
0Institution works
0Institution citations

Model signals

Opportunity 25 · ML priority 25 · Confidence 100 · Evidence 24.7

These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.

Leading disease areas

parkinsons16trials
epilepsy13trials
schizophrenia6trials
depression5trials
alzheimers4trials
multiple_sclerosis4trials
autism2trials
neuromuscular1trials
pain_neuropathy1trials
bipolar_disorder1trials

Leading indexed sponsors

Merck Sharp & Dohme LLC10trials
AbbVie4trials
Boehringer Ingelheim4trials
GlaxoSmithKline3trials
Novo Nordisk A/S3trials
Celgene2trials
Hoffmann-La Roche2trials
Karuna Therapeutics, Inc., a Bristol Myers Squibb company2trials
Eisai Limited2trials
Forest Laboratories2trials